Pharma Reviews: Sridhar Sivaram Says Stay Away From NBFCs, Consider Auto, Telecom

India's pharmaceutical sector has stock-specific opportunities, Sivaram said. Opportunity more on chemistry side than pharma side. See slower growth ...
Read more: Sridhar Sivaram Says Stay Away From NBFCs, Consider Auto, Telecom